Healthcare
Live Price
Offline$0.0763
-4.16% today
Window Change
-70.78%
Window
Jun 26, 2025 → May 14, 2026
Coverage: 223 bars · Jun 26, 2025 → May 14, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Nuvation Bio Inc. (NUVB-WT) is a Healthcare stock with a market cap of $26.15M and listed on NYSE. The stock last traded around $0.08 and down 70.8% across the available one-year price window (Jun 26, 2025 → May 14, 2026). Baseline metrics include revenue growth of +699.0%, EPS growth of +71.6%, a dividend yield of 0.0%. What stands out right now is revenue +699.0%, EPS +71.6%, free cash flow -33.1% with operating margin -338.7% and ROIC -41.0%. Valuation already assumes a fairly strong business story at price/sales 24.7. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines NUVB-WT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
NUVB-WT
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
NUVB-WT Max Drawdown
-92.14%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for NUVB-WT and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for NUVB-WT
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.